2-chloro-5-(1H-pyrrol-1-yl)pyridine, 95.0%, 500mg

3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 95.0%, 5g

O-Butyl Dabigatran Ethyl Ester (Dabigatran Impurity), 97%, 50mg

4'-bromo-3-(4-chlorophenyl)-3'-fluoropropiophenone, 97.0%, 1g

2,2-Dimethylchroman-6-sulfonyl chloride, 95%, 1g

Reaktionsgefäß, DN150, 5,0 l, zylindr.,, gradu., Temp.-Vak.-Mantel, Entleerungsventil., 1 Stück

2-(2-Bromophenyl)-2-methylpropanoic acid, 1g

5-Piperidin-1-ylmethyl-furan-2-carboxylic acid, 95.0%, 50mg

N-Methyl-1-(4-nitrophenyl)methanamine, 97.0%, 10g

4,4,5,5-Tetramethyl-2-(2,3,4-trifluorophenyl)-1,3,2-dioxaborolane, 97%, 5g

3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[[(1S,2S)-2-(dimethylamino)cyclohexyl]amino]-3-cyclobutene-1,2-dione, 97%, 100mg

5,6-Dihydrodicyclopentadiene>95.0%(GC)25g

IPTG, 100 g